Page 2 of bharat biotech

Bharat Biotech, Intranasal covid vaccine, covid vaccine, health news, pharma news,

Bharat Biotech expects DGCI’s nod for intranasal COVID-19 vaccine this month

Ella said the firm completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no single…

August 2, 2022 13:40 IST

Bharat Biotech, ExcellGene, CEPI, University of Sydney, COVID-19 vaccine, health news, covid updates,

ExcellGene partners with Bharat Biotech, CEPI and Sydney University to develop ‘variant-proof’ COVID-19 vaccine

On Tuesday, ExcellGene informed that it will produce complex chimeric Spike antigens using its engineered CHOExpress-cell-based technology.

July 26, 2022 19:24 IST

Bharat Biotech, Covaxin, Lancet study, vaccine for children, health news, covid 19, coronavirus pandemic,

Germany to recognise Covaxin for travel from June 1

German Ambassador to India and Bhutan, Walter J Lindner on Thursday said the government of the European nation will start…

Updated: May 26, 2022 14:49 IST

CEPI to provide up to $19.3 m to Bharat Biotech, others for development of ‘variant-proof’ Covid vaccine

CEPI will provide funding of up to $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to…

May 11, 2022 08:09 IST

Bharat Biotech must address WHO’s Covaxin suspension to avoid EUL cancellation, says MEA

In a communication to Dr V K Paul, the convenor of a key empowered group on Covid vaccination, on Tuesday…

April 28, 2022 19:56 IST

Related News

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Big Aadhaar update from November 2025: No document upload needed — UIDAI to verify details automatically

F-1 visa denied for applicant after single question at US Consulate

India agrees to cut Russian oil imports, US may slash tariffs to 15% under new trade deal: Report

India agrees to cut Russian oil purchase, open agriculture- Trump may reduce tariff to 15%: Report

Techie discusses move back to India amid Green Card concerns.

Techie plans return to India after 15 years in US amid green card uncertainty, says ‘want to move before…’

Asia Cup Trophy Controversy: India refuses award, PCB proposes special handover

Asia Cup 2025 Trophy row: PCB chief Mohsin Naqvi sends firm message to BCCI, says ‘If you want the trophy, we…’

Kylaq races ahead as Syros stalls in sub-4 metre SUV battle

Business35 min ago

The Kia Syros and Skoda Kylaq were highly anticipated and received 40,000 bookings. However, the Skoda Kylaq has maintained steady sales while the Syros has seen a decline due to Kia’s pricing strategy. Skoda’s balanced pricing has led customers towards its competitor, the Sonet. U

View all shorts